| LA | |
|---|---|
| Post | - |
| Pre | - |
| M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | - | - | - | - | - | 24.0 | 35.5 | 0.5 | - | - | 60.0 |
| 1 | - | - | - | - | - | 240.5 | 409.0 | 1.5 | 2.5 | - | 653.5 |
| LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
|---|---|---|---|---|---|---|---|---|
| Post | - | - | - | - | - | - | - | - |
| Pre | - | - | - | - | - | - | - | - |
| AME | |
|---|---|
| 0 | - |
| 1 | - |
| LOP1 | LOP2 | LOP3 | LOP4 | Total | |
|---|---|---|---|---|---|
| Post | - | - | - | - | - |
| Pre | - | - | - | - | - |
| central brain | |
|---|---|
| 0 | 3.5 |
| 1 | 3.0 |
Number of post synapses: 120
Number of pre synapses: 1307
Number of output connections: 5450
Coverage factor: 1.1
Columnar completeness: 0.21
Area completeness: 0.37
Cell size (columns): 102
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
Number of post synapses: 0
Number of pre synapses: 0
Number of output connections: 0
Coverage factor: 0
Columnar completeness: 0
Area completeness: 0
Cell size (columns): 0
| instance | NT | total connections | connections /#MeVPMe10 (L) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | MeTu2a (R) | ACh | 35 | 17.5 | 30.4% | 30.4% |
| 1 | MeTu3b (R) | ACh | 27 | 13.5 | 23.5% | 53.9% |
| 2 | MeTu2b (R) | unclear | 10 | 5.0 | 8.7% | 62.6% |
| 3 | R7d (R) | His | 7 | 3.5 | 6.1% | 68.7% |
| 4 | Cm14 (R) | GABA | 5 | 2.5 | 4.3% | 73.0% |
| 5 | Dm-DRA1 (R) | Glu | 5 | 2.5 | 4.3% | 77.4% |
| 6 | MeTu3a (R) | ACh | 5 | 2.5 | 4.3% | 81.7% |
| 7 | Cm22 (R) | GABA | 4 | 2.0 | 3.5% | 85.2% |
| 8 | Cm28 (R) | unclear | 3 | 1.5 | 2.6% | 87.8% |
| 9 | Cm33 (R) | GABA | 2 | 1.0 | 1.7% | 89.6% |
| 10 | MeVPMe8 (R) | Glu | 2 | 1.0 | 1.7% | 91.3% |
| instance | NT | total connections | connections /#MeVPMe10 (L) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | MeTu3b (R) | ACh | 1,675 | 837.5 | 30.8% | 30.8% |
| 1 | MeTu3a (R) | ACh | 1,093 | 546.5 | 20.1% | 51.0% |
| 2 | Cm22 (R) | GABA | 722 | 361.0 | 13.3% | 64.3% |
| 3 | Cm20 (R) | GABA | 633 | 316.5 | 11.7% | 75.9% |
| 4 | MeTu2b (R) | unclear | 338 | 169.0 | 6.2% | 82.1% |
| 5 | Cm14 (R) | GABA | 269 | 134.5 | 5.0% | 87.1% |
| 6 | Cm21 (R) | GABA | 176 | 88.0 | 3.2% | 90.3% |
| 7 | Cm10 (R) | GABA | 86 | 43.0 | 1.6% | 91.9% |
| 8 | MeVP39 (R) | unclear | 84 | 42.0 | 1.5% | 93.5% |
| 9 | Pm13 (R) | Glu | 57 | 28.5 | 1.0% | 94.5% |
| 10 | Mi14 (R) | Glu | 49 | 24.5 | 0.9% | 95.4% |
| 11 | MeLo5 (R) | ACh | 27 | 13.5 | 0.5% | 95.9% |
| 12 | MeTu3c (R) | ACh | 27 | 13.5 | 0.5% | 96.4% |
| 13 | MeVP31 (R) | ACh | 19 | 9.5 | 0.3% | 96.8% |
| 14 | Cm25 (R) | Glu | 18 | 9.0 | 0.3% | 97.1% |
| 15 | Cm28 (R) | unclear | 17 | 8.5 | 0.3% | 97.4% |
| 16 | aMe5 (R) | ACh | 12 | 6.0 | 0.2% | 97.6% |
| 17 | MeVP29 (R) | ACh | 12 | 6.0 | 0.2% | 97.8% |
| 18 | Cm16 (R) | Glu | 11 | 5.5 | 0.2% | 98.0% |
| 19 | Pm4 (R) | GABA | 10 | 5.0 | 0.2% | 98.2% |
| 20 | Cm3 (R) | GABA | 9 | 4.5 | 0.2% | 98.4% |
| 21 | Cm8 (R) | GABA | 8 | 4.0 | 0.1% | 98.5% |
| 22 | MeTu2a (R) | ACh | 8 | 4.0 | 0.1% | 98.7% |
| 23 | TmY10 (R) | ACh | 7 | 3.5 | 0.1% | 98.8% |
| 24 | Dm-DRA1 (R) | Glu | 6 | 3.0 | 0.1% | 98.9% |
| 25 | Dm20 (R) | Glu | 5 | 2.5 | 0.1% | 99.0% |
| 26 | aMe17a (R) | Glu | 4 | 2.0 | 0.1% | 99.1% |
| 27 | Lawf2 (R) | ACh | 4 | 2.0 | 0.1% | 99.2% |
| 28 | MeVC27 (L) | unclear | 4 | 2.0 | 0.1% | 99.2% |
| 29 | MeVP15 (R) | ACh | 4 | 2.0 | 0.1% | 99.3% |
| 30 | Tm_unclear (R) | GABA | 4 | 2.0 | 0.1% | 99.4% |
| 31 | Cm18 (R) | Glu | 3 | 1.5 | 0.1% | 99.4% |
| 32 | Dm8b (R) | Glu | 3 | 1.5 | 0.1% | 99.5% |
| 33 | aMe4 (R) | ACh | 2 | 1.0 | 0.0% | 99.5% |
| 34 | aMe9 (R) | ACh | 2 | 1.0 | 0.0% | 99.6% |
| 35 | Cm-DRA (R) | ACh | 2 | 1.0 | 0.0% | 99.6% |
| 36 | Cm7 (R) | Glu | 2 | 1.0 | 0.0% | 99.7% |
| 37 | Mi15 (R) | ACh | 2 | 1.0 | 0.0% | 99.7% |
| 38 | T2 (R) | ACh | 2 | 1.0 | 0.0% | 99.7% |
| 39 | Tm35 (R) | Glu | 2 | 1.0 | 0.0% | 99.8% |